Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer

doi:10.3748/wjg.v11.i5.634

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3373)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

417

HTML

2544

Figures (1-7)

213

Tables (1-2)

199

Sum=3373

Feb 7, 2005 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Feb 7, 2005; 11(5): 634-640
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.634

Table 2 Antisense accessible sites and their complementary oligonucleotide sequences selected by random oligonucleotide library/RNase H cleavage combined with RNADraw analysis.

Serial number	Base sequence	Origination-end sites	Base pair
ODN₁	AGATGACGACCCCATAGAGG	207-226	20 bp
AS-ODN₁	CCTCTATGGGGTCGTCATCT
ODN₂	GAGCTGGAAGGCTGGGAGCC	187-206	20 bp
AS-ODN₂	GGCTCCCAGCCTTCCAGCTC
ODN₃	CTTCATCCACTGCCCCACTG	126-145	20 bp
AS-ODN₃	CAGTGGGGCAGTGGATGAAG
ODN₄	AGGACCACCGCATCTCTACA	44-63	20 bp
AS-ODN₄	TGTAGAGATGCGGTGGTCCT

Citation: Tong QS, Zheng LD, Chen FM, Zeng FQ, Wang L, Dong JH, Lu GC. Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer. World J Gastroenterol 2005; 11(5): 634-640
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/634.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i5.634